What’s new
Oxford Cancer Biomarkers appoints Nick McCooke as its CEO
Oxford Cancer Biomarkers has appointed Nick McCooke as CEO, a key growth milestone for the company which aims to benefit
Read More
14, Aug, 2018
Quintiles Forms New Biomarker Research and Development Company
Professors David Kerr and Nick La Thangue offer oncology consulting and biomarker R&D activities spun out from the University of
Read More
14, Aug, 2018